Regulatory Affairs Consulting Services in India
End-to-end regulatory affairs solutions in India for product approvals across the pharmaceuticals, MedTech, nutrition, cosmetics, biologics, and veterinary industries.

Services We Offer
Top Regulatory Affairs Solutions In India by Artixio
India’s healthcare industry has grown into one of the world’s major hubs, driven by government incentives, rising R&D investments, and a strong demand for affordable therapies. As the domestic pharmaceutical sector—currently valued at over $50 billion—heads toward a projected $130 billion by 2030, companies are placing greater focus on tailored regulatory affairs strategies to stay competitive and compliant in this dynamic market.
Although the scale and opportunity are growing, product registration in India remains complex. It involves coordination between central and state authorities, multiple legislations, and alignment with global standards like ICH, WHO GMP, and ISO. As a regulatory affairs company in India, Artixio helps simplify this process with clear guidance and hands-on support.
Regulatory Authorities in India
Authority | Scope |
---|---|
Central Drugs Standard Control Organization (CDSCO) | Central authority for new drug approvals, clinical trials, import licenses, and post-market surveillance. |
Drug Controller General of India (DCGI) | Heads CDSCO and leads national policy for drugs and medical devices. |
State Drug Licensing Authorities (SLAs) | Approve manufacturing and sales licenses at state level. |
FSSAI (Food Safety & Standards Authority of India) | Regulates food supplements and nutraceuticals. |
Regulatory Affairs Process In India

Step 1 - Product Classification
- New drug: Not previously approved in India
- Generic drug: Same active ingredient as before
- Biosimilar or Vaccine
- Medical Devices: Class A to D, based on the risk
- Cosmetics/Nutraceuticals
Step 2 - Appointment of Authorized Indian Agent (For Imports)
Step 3 - Documentation and Dossier Preparation
- Common Technical Document (CTD/eCTD) format for drugs
- Device Master File (DMF) for medical devices
- Product composition and specifications
- Stability and toxicity studies
- Clinical trial data (if applicable)
- Manufacturing site GMP certification
- Product labels and package inserts
- Free Sale Certificate (for imported products)
- Product testing data (for cosmetics or food products)
Step 4 - Clinical Trial Authorisation
- Submit the approval application via the SUGAM online portal
- Trials must be in compliance with Schedule Y of the Drugs and Cosmetics Rules
- Register the trials in the Clinical Trials Registry India (CTRI)
- Ethics committee clearance and GCP compliance are required
Step 5 - Submission of Application for Product Approval
Step 6 - Review and Evaluation by Regulatory Authorities
- Technical validity
- Indian pharmacopoeial standards compliant
- Manufacturing facility inspection report
- Clinical trial data or literature evidence
- Labelling and packaging compliance
Step 7 - Product Approval & Post-Market Obligations
- Submit adverse event and PSUR reports
- Batch testing release and documentation
- Undergo audits, when required
Why Artixio?




Are you launching your product in India ?
FAQs
Are CTD/eCTD formats accepted in India?
Is a separate license needed for each state in India?
What is the validity period of product registrations in India?
Is prior approval in US/EU markets sufficient for Indian registration?
Still Have Questions ?
Specialized Registration Services Across Multiple Industries
Expert Regulatory Services To Streamline Compliance

Regulatory Intelligence & Strategy

Medical & Technical Writing

Publishing & Submission






Regulatory Affairs Across Multiple Countries

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

European

Thailand

Indonesia

Philippines

USA

Japan

Qatar
